Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Liver Neoplasms × ferumoxides × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1

Interventions

Sorafenib 20 Bevacizumab 13 pembrolizumab 9 durvalumab 7 Ipilimumab 6 Talaporfin 5 Nivolumab 5 Drug Therapy 5 spartalizumab 4 lenvatinib 4 atezolizumab 4 regorafenib 3 derazantinib 3 Ramucirumab 3 Photochemotherapy 3 Leucovorin 3 Injections 3 Fluorouracil 3 Doxorubicin 3 tremelimumab 2 toripalimab 2 seocalcitol 2 phosphomannopentaose sulfate 2 liposomal doxorubicin 2 exatecan 2 brivanib 2 Phototherapy 2 Oxaliplatin 2 Oncolytic Virotherapy 2 Irinotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00307866 2009-05-18

Identification of Hepatic Lesions

Bayer

Phase 3 Completed

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡